On November 4, Axinn partner Chad Landmon co-presented, "Biosimilars Action Plan Scorecard: Is FDA Helping Adoption?" at the GRx+Biosims Conference in North Bethesda, Maryland. Chad addressed the ways FDA policy is affecting both the US and global biosimilars markets.

This event featured top officials and subject matter experts who shared their knowledge on how to succeed in generic and biosimilar development, the regulatory process and approvals, and the evolving policy landscape.

Press Coverage: 

• Regulatory Focus